{
    "code": "01040704",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01040704",
    "time": "2019-11-01 03:13:34",
    "許可證字號": "衛署藥製字第040704號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/12\/31",
    "發證日期": "85\/12\/19",
    "許可證種類": "製　劑",
    "舊證字號": "12009652",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104070400",
    "中文品名": "&quot;紐約&quot;溴化普泮夕林糖衣錠１５公絲",
    "英文品名": "PROPANTHELINE BROMIDE S.C. TABLETS 15MG &quot;N.Y.&quot;",
    "適應症": "胃、十二指腸潰瘍、胃酸過多、幽門痙攣、結腸過敏及痙攣、膽囊痙攣、輸尿管及膀胱痙攣、多汗症、節制涎液分泌",
    "劑型": "119糖衣錠",
    "包裝": "10-1000粒瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "PROPANTHELINE BROMIDE",
    "主製造廠": {
        "申請商名稱": "0201504200  人人化學製藥股份有限公司",
        "申請商地址": "桃園市中壢區南園二路３號",
        "主製造廠": "",
        "製造廠名稱": "6105140025  保瑞藥業股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208004310",
            "成分名稱": "PROPANTHELINE BROMIDE",
            "含量描述": "15",
            "含量": "15.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010407040001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01040704&Seq=001&Type=9"
        }
    ]
}